tiprankstipranks
CytoTools AG (DE:T5O)
XETRA:T5O
Germany Market

CytoTools AG (T5O) Financial Statements

0 Followers

CytoTools AG Financial Overview

CytoTools AG's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; CytoTools AG is scheduled to report earnings on June 24, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 4.10M€ 529.48€ 804.79K€ 1.57M€ 1.48M
Total Assets€ 22.36M€ 18.27M€ 21.58M€ 22.30M€ 17.33M
Total Debt€ 418.88K€ 243.41K€ 0.00€ 0.00€ 0.00
Net Debt€ -3.68M€ 242.88K€ -804.79K€ -1.57M€ -1.48M
Total Liabilities€ 587.17K€ 399.98K€ 259.91K€ 369.73K€ 128.69K
Stockholders Equity€ 21.77M€ 17.87M€ 21.32M€ 21.93M€ 17.20M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in EUR

CytoTools AG Earnings and Revenue History

CytoTools AG Debt to Assets

CytoTools AG Cash Flow

CytoTools AG Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis